
Knowles’ first quarter results drew a positive market response, with better-than-expected revenue despite a substantial year-over-year decline. Management credited the quarter’s performance to ongoing strength in medtech and specialty audio, as well as normalization of distributor inventory levels in industrial channels. CEO Jeffrey Niew emphasized the company’s proximity manufacturing model, which limits direct tariff exposure to less than 5% of revenue, and noted, “our backlog for the medtech and specialty audio segment for Q2 is strong.” Meanwhile, the Precision Device segment benefited from improved bookings, with new products and a reduction in distributor inventories supporting a more stable demand environment.
Is now the time to buy KN? Find out in our full research report (it’s free).
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
In the coming quarters, our analysts will be monitoring (1) the pace of revenue recovery and margin expansion as capacity utilization improves, (2) evidence of continued backlog growth and normalized inventory levels in key end markets, and (3) the impact of ongoing tariff developments on both direct and indirect costs. Progress in specialty film production and execution of potential acquisition opportunities will also be important drivers of Knowles’ performance.
Knowles currently trades at $17.21, up from $15.66 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free).
Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.
While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
| Aug-12 | |
| Jul-24 | |
| Jul-24 | |
| Jul-23 | |
| Jul-23 | |
| Jul-23 | |
| Jul-06 | |
| Jul-06 | |
| Jul-01 | |
| Apr-24 | |
| Apr-23 | |
| Apr-23 | |
| Apr-23 | |
| Apr-23 | |
| Apr-13 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite